Tag: Novo
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...
FDA Petitioned to Prevent Compounders from Producing Ozempic Generics
Novo Nordisk, the pharmaceutical company, has requested the Food and Drug Administration (FDA) to stop compounding pharmacies from producing generic versions of its popular weight loss drug semaglutide. The company believes that the medication...